Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
553 1 |
Ultima descărcare din IBN: 2023-11-22 23:40 |
SM ISO690:2012 STAMATI, Adela. Strategia actuală a tratamentului de durată cu SS-Blocante în cardiomiopatia dilatativă la copii
. In: Buletin de Perinatologie, 2008, nr. 1(37), pp. 39-42. ISSN 1810-5289. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Buletin de Perinatologie | ||||||
Numărul 1(37) / 2008 / ISSN 1810-5289 | ||||||
|
||||||
Pag. 39-42 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
In out study it has been evaluated clinical and hemodynamic effects and treatment tolerability in chronic combined administration at 32 children with DCM and congestive heart failure Association of Carvedilol to conventional treatment has contributed to the improvement of clinical and hemodynamic indexes at patients from the main group in comparison with the referential group. The tolerability of Carvedilol proved to be good; the adverse effects were unique, passengers and only one child needed
treatment interruption. |
||||||
|
DataCite XML Export
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'> <creators> <creator> <creatorName>Stamati, A.T.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> </creators> <titles> <title xml:lang='ro'>Strategia actuală a tratamentului de durată cu SS-Blocante în cardiomiopatia dilatativă la copii </title> </titles> <publisher>Instrumentul Bibliometric National</publisher> <publicationYear>2008</publicationYear> <relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1810-5289</relatedIdentifier> <dates> <date dateType='Issued'>2008-01-01</date> </dates> <resourceType resourceTypeGeneral='Text'>Journal article</resourceType> <descriptions> <description xml:lang='en' descriptionType='Abstract'>In out study it has been evaluated clinical and hemodynamic effects and treatment tolerability in chronic combined administration at 32 children with DCM and congestive heart failure Association of Carvedilol to conventional treatment has contributed to the improvement of clinical and hemodynamic indexes at patients from the main group in comparison with the referential group. The tolerability of Carvedilol proved to be good; the adverse effects were unique, passengers and only one child needed treatment interruption.</description> <description xml:lang='ru' descriptionType='Abstract'>Представлены результаты длительного традиционного лечения и комбинированного ß-блокатором карведилолом у 32 детей с ДКМП и застойной сердечной недостаточностью. Эффективность оценивалась клиническим и гемодинамическими критериями по определенному протоколу. Предварительные результаты показали, что у детей, получавших карведилол (основная группа), отмечались более выраженный клинический и гемодинамический эффект по сравнению с контрольной группой. Переносимость препарата оказалась хорошей, побочные явления были отмечены в единичных случаях, и только один ребенок нуждался в отмене карведилола.</description> </descriptions> <formats> <format>application/pdf</format> </formats> </resource>